All Q2 FY27 results →
ES

Essen Speciality

Q2 FY27

Essen Speciality Q2 FY27 results statement: Revenue & Margins

Q2 FY27 results statement: what the company reported on revenue, margins and projects.

Price₹120
Market cap₹298 Cr
Updated21 Oct 2026
Read3 min read

Based on Essen Speciality's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.

The short version

Revenue from operations for the quarter ended September 30, 2026: Rs. Quarterly Figures (Q2 Sept 30, 2026): - EBITDA: Rs.

From Essen Speciality's Q2 FY27 earnings-call transcript · updated 21 Oct 2026.

Revenue & Sales Performance

  • Revenue from operations for the quarter ended September 30, 2026: Rs. 2,890.83 lakhs.
  • Revenue from operations for the quarter ended September 30, 2025: Rs. 4,835.33 lakhs.
  • Year-on-year change: Decrease of Rs. 1,944.5 lakhs (approximately a 40.2% decline).
  • Other income for the quarter ended September 30, 2026: Rs. 4.70 lakhs (vs. Rs. 0.73 lakhs in 2025).

2 more points from Essen Speciality's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Essen Speciality said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The provided document does not contain any investor presentation or specific information on capex, capacity expansion, or new plant/project details, including amounts, status, or timelines. The file consists of financial results, balance sheets, cash flow statements, audit reports, and regulatory disclosures without mention of such initiatives.

Fundraising & Capital Structure

See what Essen Speciality said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The investor presentation does not explicitly report or mention any details regarding: - Order book - Order inflow - Pending orders The document contains financial results (income, expenses, profit/loss), assets and liabilities, and cash flow statements for the half year ended September 30, 2026, but does not provide specific data on orders or order status.

Essen Speciality — Quarterly revenue & net profit

Revenue Net profit Net loss
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27

Q2 FY27 figures are not in this chart yet. Latest shown: Jun 2026 (Q1 FY27). The Q2 FY27 numbers from the filing are in the analysis on this page.

Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹32 Cr, net profit ₹0 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Essen Speciality and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Essen Speciality Q2 FY27 results?

Revenue from operations for the quarter ended September 30, 2026: Rs. Quarterly Figures (Q2 Sept 30, 2026): - EBITDA: Rs.

What is Essen Speciality share price analysis?

Essen Speciality currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹298 Cr. Investors should review the full earnings analysis for detailed insights.

Is Essen Speciality planning capital expenditure?

The provided document does not contain any results statement or specific information on capex, capacity expansion, or new plant/project details, including amounts, status, or timelines.

Keep Essen Speciality on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.